Skip to the page

Data / Form D filings / ReEngage Therapeutics, Inc.

ReEngage Therapeutics, Inc.: Form D filings

ReEngage Therapeutics, Inc., a health care company in Houston, TX, filed 3 Form D notices with the SEC between 2024 and 2025. The latest, on July 1, 2025, reports $365,000 sold of a $8 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2450 HOLCOMBE BLVD. SUITE 1200, Houston, TX, 77021
Phone
(215) 400-0133
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2022524

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 1, 2025Amendment$8,000,000$365,000$7,635,0006Jun 10, 2025sec.gov
Jun 18, 2025New notice$8,000,000$250,000$7,750,0001Jun 10, 2025sec.gov
Dec 16, 2024New notice$3,000,000$65,000$2,935,0005Dec 9, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas KimExecutive Officer, Director

Other health care companies in Texas that filed recently

Every Form D from the week of Jun 30, 2025 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ReEngage Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.